
Dr R. Phipps AgBioView post April 3, 2001
Plant transformation is a powerful tool used to manipulate gene expression
in order to study gene regulation, plant development and the control of
metabolic pathways. Whilst the use of transgenic technology in model plant
systems, such as tobacco and arabidposis, is routine in many laboratories
throughout the world, most of these studies are conducted in a controlled
environment (greenhouse) and as such, pose little risk of escape of
transgenes into the environment
The situation, however, is quite different for maize. During the last 10
years maize transformations have largely been conducted in the private
sector. This is now beginning to change, with an increase in the
development and utilization of transgenic maize plants in academic
research projects. The availability of maize transformation technology to
the many university researchers involved in maize genetics, genomics,
physiology, and breeding activities is sure to advance our knowledge and
understanding of this important crop species. Unlike studies with
arabidopsis it is likely that most transgenic maize plants used by
university researchers will be grown not in glasshouses, but in field
conditions. Currently experimental transgenic maize plants are grown
primarily by the private sector at a limited number of field sites. As the
use of maize transgenics in public-sector research increases, so too will
the number of locations and the geographic range in which these
transgenics are planted. Such a situation increases the risk of
unintentional cross-pollination of non-transgenic maize plants by
experimental transgenic maize plants. While it is unlikley that such a
scenario would not effect commercial grain or result in the recall of food
products from grocery shelves, the potential for introduction of regulated
transgenes into the food chain exists as a real issue. The possibility of
this happening is increased by one of the very strengths of the maize
research community: cooperation among individual investigators. The maize
genetics community is well-known for sharing genetic seed stocks. Thus the
potential exists for the unknowing, unwitting and unintentional
distribution of a given transgene in a 'non-transgenic' stock in which
cross-pollination by a transgenic stock goes undetected. This may lead to
unchecked contamination of non-transgenic research materials, and even
commercial grain fields, with regulated transgenes.
The concerns and scenarios presented above are unlikely to result in a
situation of the economic magnitude seen with the spread of Starlink
outside the range of that product's intended use. A more likely result, no
matter how small the risk, may be a restriction on the use of government
funds for projects involving maize transgenics. Academic researchers must
make compliance with government regulations for handling transgenic maize
plants the highest priority, and take every precaution to prevent
unintentional release of transgenes outside the confines of the experiment
in which these plants are used.
** NOTICE: In accordance with Title 17 U.S.C. Section 107, this material is distributed for research and educational purposes only. **
|
|
|
Last Updated on 4/5/01 Email: information@biotech-info.net |
|